The National Clinician Consultation Center (NCCC) is a unique teleconsultation resource that provides health care providers of all experience levels with timely and evidenced-informed responses to clinical questions related to prevention, screening and management of HIV and viral hepatitis C (HCV) as well as substance use disorders.
HIV Management Service (Warmline): 800-933-3413
For questions about HIV/AIDS, including antiretroviral therapy, HIV clinical manifestations, and laboratory evaluation.
Perinatal HIV Consultation and Referral Services (Perinatal HIV Hotline): 888-HIV-8765 (888-448-8765)
For questions about the care of HIV-infected pregnant women as well as indications and interpretations of rapid and standard HIV tests. Available 24 hours/day, 7 days/week.
Pre-Exposure Prophylaxis Service (PrEPline): 855-HIV-PrEP (855-448-7737)
For questions about the initiation and management of HIV pre-exposure prophylaxis.
Substance Use Management (Substance Use Warmline): 855-300-3595
For questions about substance use evaluation and management, especially medication options for substance use disorder treatment.
Hepatitis C Management: 844-437-4636 or 844-(HEP-INFO)
For questions about screening/testing, evaluation, and treatment of hepatitis C.
Post-Exposure Prophylaxis Hotline (PEPline): 888-HIV-4911 (888-448-4911)
For questions about the initiation and management of occupational or non-occupational post-exposure prophylaxis for HIV and other bloodborne pathogens.
If you are trying to reach us regarding an occupational PEP question outside of standard operating hours, please check out our PEP Quick Guide for Occupational Exposures.
Online Case Submission (e-CCS Online Consultation)
For electronic submission of HIV, HCV, PrEP and/or substance use consultation requests, please visit our website for the specific consultation type you seek, www.nccc.ucsf.edu.
|Title||Publish Date||Review Date|
|Integrating Behavioral Health into Primary HIV Care — Covering the Bases||8/16/2021|
|HIV Infection in Adults: Initial Management||4/15/2021|
|Management of Alcohol Use Disorder||11/24/2020||5/18/2021|
|Direct-acting Antiviral (DAA) Prior Authorization Letter Templates||6/10/2020|
|COVID-19 Resources for HIV Providers||3/20/2020||7/1/2021|
|Myths about Providing HCV Treatment to People with HIV with Substance Use Disorder(s)||11/27/2018||7/26/2021|
|Flyer: Hepatitis C Screening and Treatment in People with HIV||6/29/2018||11/19/2019|
|Hep C Free Postcard||5/31/2018||11/29/2019|
|Passport to Cure||3/9/2018||11/29/2019|
Taking the Best of the Rapid Testing in Labor and Delivery Project to Fresno, CA: Fresno Perinatal HIV Summit – October 26, 2011
“I learned that HIV patients are the same as other patients with chronic disease and need our attention and care.”
Despite successful uptake of initiatives to increase rapid testing in labor and delivery hospitals throughout...